Jun 10, 2021 / 05:20PM GMT
Nathan Allen Rich - Goldman Sachs Group, Inc., Research Division - Research Analyst
Okay. Great. Good afternoon, everyone. My name is Nathan Rich, and I cover the dental space here at Goldman Sachs. Thanks, everyone, for joining for this session with Henry Schein, a leading distributor of products, technology and services to both dental and medical practitioners. I'm joined for this session by Stanley Bergman, the company's Chairman and CEO; as well as Steve Paladino, the company's CFO. Steve, I believe you wanted to start with a disclosure statement first, and then we'll pass it over to Stanley to share some opening remarks. I'd also just like to remind everyone -- I think you know the drill by now. (Operator Instructions)
So with that, Steve, why don't I turn it over to you?
Steven Paladino - Henry Schein, Inc. - Executive VP, CFO & Executive Director
Okay. Thank you, Nathan. I'd just like to note that certain comments made during this call may include information that's forward-looking. And as people know, the risks and uncertainties involved in
Henry Schein Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot